Sarepta Therapeutics buy tamam
Start price
09.01.18
/
50%
€48.59
Target price
04.11.21
€153.34
Performance (%)
57.44%
End price
05.11.21
€76.50
Summary
This prediction ended on 05.11.21 with a price of €76.50. The BUY prediction by tamam for Sarepta Therapeutics saw massive gains of 57.44%. tamam has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Sarepta Therapeutics | 4.326% | 4.326% | 6.136% | 102.519% |
iShares Core DAX® | 0.476% | -0.039% | 13.342% | 17.330% |
iShares Nasdaq 100 | 1.290% | 0.504% | 40.099% | 50.534% |
iShares Nikkei 225® | 1.300% | -2.135% | 19.861% | 4.937% |
iShares S&P 500 | 0.829% | 0.193% | 29.756% | 43.432% |
Comments by tamam for this prediction
In the thread Sarepta Therapeutics diskutieren
Sarepta continues to be a core buy in biotech
In today´s investor update management guided for fourth quarter revenue of $57.3 million and full year 2018 Exondys 51 revenue in the range of $295 million to $305 million (roughly double that of 2017).
tamam stimmt am 09.01.2018 der Outperform-Einschätzung der institutionellen Analysten zu.
In the thread Trading Sarepta Therapeutics
Die von tamam gewählte maximale Laufzeit wurde überschritten